NCT03290677View on ClinicalTrials.gov

Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor Therapy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 17, 2018

Primary Completion Date

September 30, 2023

Study Completion Date

November 30, 2023

Conditions
Lung Cancer
Interventions
PROCEDURE

Cryoablation

This involves passing a special needle into the body (cryoprobe) to freeze tumor and kill a small part (not all) of the cancer. The immune system will respond to the damage caused by freezing part of the tumor.

PROCEDURE

Biopsy

Removing a small piece of the affected area to confirm cancer

Trial Locations (1)

02214

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

William M. Wood Foundation

UNKNOWN

lead

Massachusetts General Hospital

OTHER

NCT03290677 - Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor Therapy | Biotech Hunter | Biotech Hunter